Immunogenomic classification of hepatocellular carcinoma patients for immune check-point inhibitors therapy:<i>cui bono</i>?

Authors: Ruben Hernaez, Matias A Avila

Published: 2022-05-23

DOI: 10.1136/gutjnl-2022-327132

Source: Full article

---

Abstract

No abstract found.